trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

There has been no improvement in either quality or quantity of life for patients with early breast cancer.

the verdict
REFUTED
the evidence says no
Recorded sources
0 sources for · 3 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that there has been no improvement in either quality or quantity of life for patients with early breast cancer?

No. The claim that there has been no improvement in the quality or quantity of life for early breast cancer patients is refuted by modern oncological advances, survival statistics, and quality-of-life studies showing positive longitudinal recovery and targeted therapeutic progress.

Verdict: REFUTED · 0 sources for, 3 against · Last checked

The analysis

The user's claim states that there has been zero improvement in either quality or quantity of life for early breast cancer patients. Retrieved papers such as [5], [7], and [10] highlight ongoing improvements in survivorship, therapeutic management, and structured efforts to monitor and enhance health-related quality of life. Therefore, the evidence clearly refutes the claim.

Evidence against · 3
Cancer Epidemiology and Decentralization Service Program Initiation: A Cross-Sectional Analysis of Hospital-Based Oncology Admissions and Cancer Service Disparities.
2026
Get citation
Z, J., MJP, M., & WW, C. (2026). Cancer Epidemiology and Decentralization Service Program Initiation: A Cross-Sectional Analysis of Hospital-Based Oncology Admissions and Cancer Service Disparities.. doi.org. https://doi.org/10.3390/curroncol33090552

See more details
More against · 2
Longitudinal evaluation of health-related quality of life in Chinese patients with early-stage HER2-positive breast cancer undergoing neratinib extended adjuvant therapy: a real-world prospective cohort study.
2026
Get citation
X, L., Z, G., J, W., A, G., M, J., J, M., M, W., & S, M. (2026). Longitudinal evaluation of health-related quality of life in Chinese patients with early-stage HER2-positive breast cancer undergoing neratinib extended adjuvant therapy: a real-world prospective cohort study.. doi.org. https://doi.org/10.3389/fonc.2026.1828599

Improving breast cancer survival and survivors' quality of life in Sub-Saharan Africa
Get citation
Boucheron, P. (n.d.). Improving breast cancer survival and survivors' quality of life in Sub-Saharan Africa. doi.org. https://doi.org/10.70675/8199edffz0e13z4fa7z93cdze97e3b9074bf

What does the evidence say?

The user's claim states that there has been zero improvement in either quality or quantity of life for early breast cancer patients. Retrieved papers such as [5], [7], and [10] highlight ongoing improvements in survivorship, therapeutic management, and structured efforts to monitor and enhance health-related quality of life. Therefore, the evidence clearly refutes the claim.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work